2026 ADA/EASD Consensus Report Recommends Screening for Hypercortisolism in Patients with Difficult-to-Control Type 2 Diabetes
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Corcept Therapeutics, Inc. (NASDAQ: CORT) | Delayed: 107.50 -8.78 (7.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $116.28 | 52 Week High | $10.00 | |||
| Open | $115.16 | 52 Week Low | $3.22 | |||
| Day High | $115.73 | P/E | N/A | |||
| Day Low | $107.33 | EPS | $-0.46 | |||
| Volume | 809,796 | |||||
